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Abstract 
Purpose: To develop a rapid detection method for Rift Valley fever virus (RVFV) diagnosis. 
Methods: According to the reference sequences of RVFV published in GenBank, nine overlapping 
polymerase chain reaction (PCR) primers and four specific reverse transcription loop-mediated 
isothermal amplification (RT-LAMP) primers were designed using DNAStar and LAMP primer design 
software, respectively. Based on the synthesis of a conserved part of the RVFV S segment gene 
sequence using overlapping PCR, RT-LAMP assay was first established and evaluated after a series of 
tests, including, optimization of reaction conditions, and sensitivity and specificity tests. 
Result: A target RVFV S segment gene fragment of 288 bp was synthesised. The optimal reaction 
conditions for RT-LAMP assay were 63 °C for 45 min: the assay has a specific ladder-like pattern of 
amplification bands from about 120 bp. The lowest target gene copy number of RT-LAMP for RVFV 
detection was 70 copies. The assay showed good specificity as only the synthesised target RVFV gene 
was amplified with no amplification for the detection of Peste des petits ruminants virus, Epidemic 
encephalitis B virus, E. coli, Pasteurella multocida, or Salmonella. 
Conclusion: This study provides a rapid, sensitive, specific RT-LAMP method for RVFV detection. 
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Rift Valley fever (RVF), resulting from the RVF 
virus (RVFV), is an acute and febrile infection of 
both ruminants and humans [1]. It was first found 
in the Great Rift Valley in Kenya in 1930 [1]. 
Animals such as sheep, goats, and cattle are the 
species mostly affected by the infection. 
Epidemics are characterized by the occurrence 
of fever, blood diarrhea, and abortion in pregnant 
animals. When infected by RVFV, pregnant 
dams show an abortion rate of 90 – 100 %. The 
mortality rate for adult animals of different 
species varies in the range 10 to 60 %, and that 
of newborn lambs reaches 90 – 100 % [2-4]. 
Humans infected by the virus have moderate 
symptoms such as chills, headache, and pain in 
the extremities (that is, influenza-like symptoms) 
or there may be other unapparent symptoms. 
Infection usually lasts for several days and may 
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lead to retinal injury, temporary or permanent 
blindness, encephalitis, hemorrhagic hepatitis, 
and, in serious cases, even death [2-5]. Heavy 
economic losses have been inflicted on countries 
and areas as a result of RVF epidemics and the 
threat to human health posed by RVF is serious 
as well. RVF has now become officially notifiable 
to the International Epizootic Office (OIE), and is 
listed in category A of the directory of animal 
diseases [1]. RVFV is an RNA virus in the genus 
Phlebovirus (family Bunyaviridae); its virions are 
spherical, enveloped, and 90–110 nm in size [1]. 
Although RVFV shows common resistance to the 
outside environment, it presents strong 
transmission capability. It can be transmitted by 
aerosol, touch, or consumption of infected animal 
tissue, and vertically via the placenta, as well as 
by mosquito bites [5-7]. As a result of the broad 
range of transmission modes, and also for 
climatic and geographical reasons, RVFV attacks 
occur periodically with high frequency and are 
difficult to control. RVFV is a typosis in some 
African countries and areas, but has spread to 
areas of the Mediterranean coast and Middle 
East, showing its potential to spread to areas 
outside of Africa [1]. Previous reports have 
indicated that RVFV has been isolated in from 
over 30 mosquito species [5] of mosquito. As 
these mosquitoes are distributed around the 
world, RVFV is prone to spread to Europe, 
America, and other non-epidemic areas [5,8-10]. 
Indeed, with the development of international 
trade in animal and animal products, population 
migration, and climate change, the risk of RVFV 
spreading increases continually. Due to the fact 
that there are no efficient vaccines for humans or 
animals [5], controlling and conducting research 
on RVF have becoming more urgent and 
significant. 
 
Since RVFV infections do not currently occur in 
China, preventing the transmission of RVFV by 
studying RVFV control (especially rapid 
diagnosis technology) has great significance for 
public health. Loop-mediated isothermal 
amplification (LAMP), as a new nucleic acid 
amplification technology, presents high specificity 
and sensitivity, and has low equipment 
requirements for reaction, reading, and 
judgment. The amplification results are likely to 
read and judge by directly observing the variation 
in turbidity (resulting from the white precipitate of 
magnesium pyrophosphate) using the naked 
eye. Due to these advantages, LAMP has 
become a new and important research direction 
for the detection and diagnosis of many 






2 × Taq PCR Master Mix, Betaine (Z0041-1), 
DNA Marker DL 2000 (D501A), pMD19-T Vector, 
Pfu DNA polymerase, EcoR I(K2153BA), 
Primerscript RT reagent Kit (BK1901), and 
RNAiso Plus were purchased from TaKaRa 
(Japan), Bst polymerase (M0275) was obtained 
from Beijing New England Biolabs Co. Ltd., 
Peste des petits ruminants virus (live vaccine), 
epidemic encephalitis B virus (inactivation 
vaccine), Pasteurella multocida, E. coli, and 
Salmonella were provided by the animal 
quarantine Laboratory of Sichuan Agricultural 
University. 
 
Design and preparation of primers 
 
Based on the sequence of conserved segment S 
gene fragments of RVFV (accession no. 
HE687307), nine overlapping oligo primers and 
four specific primers for RT-LAMP (Table 1) were 
designed using DNAStar and Primer Explorer V4 
software (http://primerexplorer.jp/e/), respect-
tively. All of these primers were prepared by 
TaKaRa Biotechnology (Dalian) Co., Ltd, and 
diluted to their working concentrations with 
double distilled H2O (dd H2O) for subsequent 
tests. 
 
In vitro synthesis of target RVFV segment S 
gene fragments 
 
The conserved sequence fragment of the RVFV 
segment S gene (target DNA) was synthesised in 
vitro using an overlap extension PCR method 
and was then cloned into the pMD9-T vector to 
construct the recombinant plasmid (named 
pMD19-T-RS) as described elsewhere [12,13]. 
 
For the primary extension procedure, a 50 μL 
reaction volume containing 5 μL 10 × Pfu DNA 
polymerase buffer, 6 μL of dNTPs (2.5 mmol/L of 
each nucleotide), 1 μL (10 μmol/L) of each of the 
overlapping oligo primers (F1/R1, F2/R2, or 
F3/R3), 1 μL of Pfu DNA polymerase, and 36 μL 
ddH2O were used. The reaction conditions were 
94 °C for 30 s, and 72 °C for 15 min. Secondary 
extension reactions were then carried out until 
the full-length target DNA fragment product had 
been synthesised in the 50 μL volume reaction 
including 1 μL 10 × Pfu DNA polymerase buffer, 
6 μL of dNTPs, 1 μL of Pfu DNA polymerase, 
and 21 μL of each of the two overlapping 
primary/previous extension reaction products. 
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Table 1: Primers used for study of RVFV RT- LAMP detection 
 
Task and Primer 
name Sequence (5′–3′) 
Product 
size 
Overlapping PCR   
P1 ACCATCGTCCTAGTCACGAG 288 bp 
P2 TCTGATCCCTTCTAATGTCAT  
F1 TCGTCCTAGTCACGAGGTTCGCTTGCGATTTTCTGATTTCTACAATGTCGGAGAATTCC  
F2 TCAAACGTTGCACCTCCACCAGCAAAGCCTTTCCAGAGACTTATTGATCTAATAGGCCA  
F3 CCAATCTAAAAGAAGCCATATCCTGGCCTCTTGGAGAACCCTCACTAGCTTTCTTTGAC  
R1 AGGTGCAACGTTTGATGCAAAGTCTCCAAGTCCGACTCGGTATGGGAATTCTCCGACAT  
R2 CTTCTTTTAGATTGGGGAACCTTGTGAAATCACTAAGAGTCATATGGCCTATTAGATCA  
R3 TCCCTTCTAATGTCATCATTCCTGTGCACTCTAGTAGAGCTTAGGTCAAAGAAAGCTAG  
RT-LAMP   
F3 CGCTTGCGATTYTCTGAT 173 bp 
B3 GCTTCTTTYAGATTGGGGAAC  
FIP GCAACGTTTGATRCAAAGTCTCTTCTACAATGTCGGAGAATTCC 120- bp 
BIP CCTCCACCAGCRAAGCCTTTCTTGTGAAATCACTAAGAGTCAT  
 
The reaction conditions were kept the same as 
those described for the aforementioned primary 
extension procedure. 
 
The full-length target DNA fragments, from the 
previous secondary extension reaction, were 
amplified by PCR using primers P1 and P2 in a 
50 μL reaction volume containing 25 μL 2 × Taq 
PCR Master Mix, 1 μL (10 μmol/L) of each of the 
primers (P1 and P2), 3 μL of template (full-length 
target DNA fragments), and 20 μL ddH2O. The 
PCR was conducted as follows: denaturing at 95 
°C for 5 min; followed by 30 cycles at 94 °C for 
40 s, 56 °C for 40 s, and 72 °C for 45 s; the 
procedure was then terminated by an elongation 
at 72 °C for 8 min. Some 5 μL of PCR product 
was analysed in a 10 g/L agarose in TAE buffer 
gel containing 0.5 mg/mL GreenView through 
electrophoresis, which was then photographed 
under a UV imaging system (Bio-Rad). 
 
The PCR products were subsequently separated 
and purified according to the TIANgel Midi 
Purification Kit (DP209) instructions: they were 
then directly cloned into the pMD19-T Vector 
followed by a transformation into DH5α 
competent cells. Then, the recombinant plasmids 
were extracted using a TIANprep Mini Plasmid 
Kit, and were subsequently identified by PCR 
(using P1/P2 and RV-M/M13-47 as primers) and 
sequencing analysis [13]. 
 
RVFV Basic RT-LAMP reaction 
 
The RT-LAMP reaction mixture (25 μL) 
contained 2.5 μL of 10 × ThermoPol buffer, 1 μL 
(8 units) of BstDNA polymerase, 3 μL of MgCl2 
(25 mM), 3 μL of betaine (8 mM), 8 μL of dNTP 
(2.5 mM), 1 μL of each of the primers (F3 (5 μM), 
B3 (5 μM), FIP (50 μM), and BIP (50 μM)), 1 μL 
of template (the recombinant plasmids), and 2.5 
μL of ddH2O. The reaction mixture was incubated 
at 65 °C for 1 h then heated at 80 °C for 2 min in 
a water bath (DSY21-8, China): the amplified 
products were analysed in a 15 g/L agarose in 
TAE buffer gel. The results could also be seen by 
the naked eye because of either the white 
precipitate of magnesium pyrophosphate 
generated in the reaction, or the green colour 
change under 254 nm wavelength UV light upon 
the addition of diluted SYBR Green I (3280-50, 
TIANDZ, China). To confirm the specificity of 
amplification products, 10 μL of the reaction 
mixture was digested with EcoR I at 37 °C for 2 
h. 
 
Optimisation of reaction conditions 
 
To optimise LAMP assay conditions, a reaction 
mixture as described above was used. The 
reaction conditions were determined as follows: 
an incubation gradient spanning 60 °C to 66 °C 
for 1 h, and then at each of the optimum 
incubation temperatures for 30, 45, 60, and 90 
min, respectively as then terminated at 80 °C for 
2 min. In all, 5 μL of LAMP products were 
analysed using 15 g/L agarose gel 
electrophoresis. 
 
Sensitivity of RVFV RT-LAMP 
 
Using the optimum reaction system and 
conditions determined above, a 10-fold serial 
dilution of the recombinant plasmids constructed 
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here was used as a template after being 
assessed by ND-1000 ultraviolet 
spectrophotometer (Nano Drop Co., Ltd, USA), 
and compared with the RT-PCR detection 
method established in the literature [13]. 
 
Specificity of RVFV RT-LAMP 
 
The specificity of the RT-LAMP was assessed by 
comparing the recombinant plasmids constructed 
to the Peste des petits ruminants virus, Epidemic 
encephalitis B virus, Pasteurella multocida, E. 
coli, and Salmonella isolated from goats, and to a 
normal tissue sample also taken from goats. 
DNA templates were extracted using phenol-
chloroform method [12] which involves: taking 1 
mL bacteria cultures and boiling them for 5 min, 
centrifuging at 4,000 g for 10 min, then collecting 
the upper phase of approximately 500 µL and 
transferring it to a new tube, proteinase K (20 
mg/ml) 25 µL and 10 % SDS 75 µL were added, 
and the solution incubated at 55 °C for 1 h; then 
800 µL tris-phenol was added by mixing the 
extracts and inverting 10 times, spinning at 4 °C 
and 12,000 g for 5 min, then collecting the upper 
phase of about 400 µL and transferring it to a 
new tube before adding 300 µL tris-phenol and 
300 µL chloroform and mixing, spinning at 4 °C 
and 12,000 g for 5 min, then collecting the upper 
phase of about 400 µL and transferring it to a 
new tube before adding the same volume of 
chloroform and mixing, spinning at 4 °C and 
12,000 g for 5 min, then collecting the upper 
phase of about 300 µL and transferring it to a 
new tube; adding 1/10 volumes of 3 mol/L 
sodium acetate (pH 5.3) and 2 volumes of 
absolute ethanol, mixing the solution to 
precipitate total DNA, putting the tube on ice for 
30 min, spinning at 4 °C and 12,000 g for 15 min, 
and slowly discarding the upper phase so as to 
retain the DNA precipitate; rinsing the DNA 
precipitate with 70 % ethanol, and air-drying it in 
the old tube before adding 40 µL ddH2O to 
dissolve the DNA before storing it at –20 °C. The 
RNA extraction of the virus and the normal tissue 
sample, and the RT reaction were subsequently 
performed by using the RNAiso Plus reagent 





Synthesis of the RVFV S segment gene 
sequence 
 
A DNA fragment containing approximately 288 
bp was amplified using overlapping PCR (see 
Fig. 1, Lane 1). This target fragment was cloned 
into a pMD19-T vector, and the recombinant 
plasmid was identified by two types of PCR 
method and sequencing analysis. The results 
showed that the PCR products of the 
recombinant plasmid from the pMD19-T vector 
and usual primers (M13-RV, or M13-M4) 
measured 444 bp, about 156 bp longer than the 
PCR products formed when using the special 
primers (P1 or P2) (see Fig. 1, Lanes 2 and 3). 
This was indicative of the recombinant plasmid 
having been constructed, and blast analysis of 
the sequencing result of the target DNA fragment 
of RVFV (see Fig. 2) revealed that it had a 100 % 
homology with the reference sequence 
(HE687307) published in GenBank. The 
constructed recombinant plasmid was named 
pMD19-T-RS. The results indicated that the 
target DNA fragment of 288 bp-length of RVFV S 
segment gene sequence was successfully 




Figure 1: Artificial synthesis and identification of RVFV conserved segment S gene fragment. (A) Overlapping 
PCR results for the RVFV conserved segment S gene fragment; (B) PCR identification results of recombined 
plasmid; M.DL2000 DNA marker; 1 = The overlapping PCR product of the RVFV target gene fragment; 2 = PCR 
(M13-RV/M13-M4) identification product of pMD19-T-RS: 3 = PCR (P1/P2) identification product of pMD19-T-RS; 
4 = PCR (M13-RV/M13-M4) identification product of pMD19-T vector 
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  Figure 2: Sequencing result for the artificial target fragment 
 
RVFV basic RT-LAMP reaction 
 
A basic LAMP assay was carried out using 
pMD19-T-RS as a template: it was incubated at 
64 °C for 1 h, and then the amplification products 
were analysed by agarose gel electrophoresis, 
enzyme-digestion and visual inspection as 
described earlier. The results (see Fig. 3) 
showed the target template was amplified with 
ladder-like pattern bands from about 120 bp on 
the gel (Fig. 3(A), Lane 1), for which specificity 
was confirmed by the digestion products 
measuring 198 bp with EcoR I (Fig. 3(A), Lane 
3). The positive reaction could also be visualised 
by the white precipitate of magnesium 
pyrophosphate (Fig. 3(B), Tube 1) and the green 
colour produced after the addition of diluted 
Supper SYBR, while the pMD-19T vector 
template control reactions were unamplified and 
evinced no visible change (Fig. 3, Lane 2 and 
Tube 2). 
 
Optimisation of RVFV RT-LAMP reaction 
conditions 
 
The pMD19-T-RS was used as a template to 
determine the RT-LAMP reaction conditions. The 
results (shown in Fig. 4) showed that reaction 
products present in Lane 1 to Lane 4 (60-62.7 
°C) and Lane 8 to Lane 10 (45 min, 60 min and 
80 min) are separately presented in a greater 
quantity than in the Lane 5 and Lane 6 (64.3 - 
65.6 °C) and Lane 7 (30 min).  
 
The results indicated that the optimum LAMP 
conditions for a 25 μL reaction volume were 63 
°C for 45 min in order to create a high specificity 
and amplification efficiency: the optimum RT 
reaction should be the same as outlined in the 




Figure 3: RVFV basic RT-LAMP results. A = Agarose 
gel electrophoresis analysis; B = Visual inspection of 
turbidity; C = Visual inspection after adding SYBR 
Green I; M. DL2000 DNA marker; 1 = pMD19-T-RS 
LAMP products, 2 = pMD-19T vector Negative Control 
products; 3 = product from pMD19-T-RS LAMP 
products digested by EcoR I 
 
Sensitivity and specificity of RVFV RT-LAMP 
 
The sensitivity and specificity of the RVFV RT-
LAMP were assessed in the tests described 
earlier. There was evidence of the expected 
ladder-like pattern of electrophoretic bands from 
about 120 bp (see Fig. 5, Lane 4) when almost 
70 target copies (pMD19-T-RS) were detected by 
LAMP, which was 10 times more than with PCR 
(see Fig. 5, Lane 10). For the specificity, there 
was evidence of the anticipated ladder-like 
pattern in the electrophoretic bands that was only 
observed with pMD19-T-RS detection: no 
specific amplification products were obtained for 
the detection of the Peste des petits ruminants 
virus, Epidemic encephalitis B virus, E. coli, 
Pasteurella multocida, or Salmonella. 
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Figure 4: The optimisation RVFV RT-LAMP reaction 
conditions: A = Reaction temperature optimisation 
assay; B = Reaction time optimisation assay; M = 
DL2000 DNA marker; 1 to 6 denote: 60, 60.5, 61.4, 
62.7, 64.3, and 65.6 °C, respectively; 7 to 10 denote 




Figure 5: Sensitivity assay results of RVFV RT-LAMP 
on agarose gel electrophoresis. M: DL2000 DNA 
marker; 1 = 70,000 copies; 2 = 7000 copies; 3 = 700 
copies; 4 = 70 copies; 5 = 7 copies; 6: 8 = Negative 
Control; 7 to 11 denote the RT-PCR products of 





RVFV, as a mosquito-borne virus for a multitude 
of animals, is spread in many ways. It has 
caused heavy economic losses for the ruminant 
cultivation industry in the epidemic areas in 
Africa and the Middle East. Furthermore, RVFV 
is a serious threat to human health due to food 
safety problems [1]. As there is no ideal vaccine, 
developing a rapid detection and diagnosis 
technology has important agricultural and public 
health significance for RVFV control in both 
epidemic and non-epidemic areas [14]. 
Presently, apart from traditional methods such as 
virus isolation, serology diagnosis, virus 
neutralization testing, and hemagglutination 
inhibition tests, there are also RT-PCR [15], 
ELISA [2], nested RT-PCR [16], fluorescence 
RT-PCR [3], and RT-LAMP [17] technologies 
available for detecting and diagnosing RVFV. As 
there is no RVFV pathogen in China, because of 
the pathogen’s characteristics (such as being 
harmful to both human and animals, and its high 
transmissibility, pathogenicity, and pernicious-
ness), research on RVFV is seldom reported in 
China [18].  
 
Overlap PCR technology, an important in vitro 
gene synthesis bioengineering technology, can 
synthesize overlap primers based on existing 
gene sequences and obtain target gene 
fragments using overlap extension and PCR. It 
has been applied in studies of molecular biology 
areas including molecular biological diagnosis in 
the case of lesser pathogens and avoiding the 
spread of high risk pathogens [19]. By collecting 
and analyzing a large number of RVFV gene 
sequences, nine overlap PCR primers were 
synthesized. Based on the primers, 288 bp of 
segments from the conserved region of the 
nonstructural protein gene of the S segment of 
RVFV were successfully synthesized. This was 
achieved by performing overlap extension 
reactions, PCR amplification, purification, 
connection, and transformation of the PCR 
products, followed by identification, sequencing, 
and analysis of the objective gene fragments. 
The process provides safe biomaterials for 
further detection methods (PCR, LAMP, Real 
time PCR, and multiplex PCR).  
 
Research on RVFV detection in China is mainly 
based on the fluorescence RT-PCR method [18]. 
The LAMP method is rarely reported. LAMP 
detection not only presents specificity and 
sensitivity that is equal to or better than that of 
fluorescence PCR, but is also quicker and has 
lower requirements for producing results, 
reading, and judging. Owing to these 
advantages, LAMP has great laboratory and 
clinical generalization potential [11]. However, 
the high specificity, reaction characteristics, and 
primer design requirements limit the application 
of LAMP in the detection of some pathogenic 
genes. This is because simply using the default 
parameters in software such as Primer fails to 
screen appropriate primer pairs when inputting 
the conserved gene segments [12].  
 
By comparing gene sequences from the S 
segments of more than 20 strains of RVFV in the 
primer design process, the conserved objective 
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segments were selected and 4 reasonable LAMP 
experimental primers were screened and 
synthesized. Meanwhile, degenerate bases were 
used in the primer syntheses to resolve the 
differences between gene sequences and gene 
mutations in the different strains. Using the 
synthesized gene segments as templates and 
optimizing the reaction temperature and time, 
specificity and sensitivity tests were used to 
detect and evaluate the operational efficiency of 
the LAMP primers. The results showed that RT-
LAMP detection of RVFV using the synthesized 
primers exhibits favorable specificity and 
sensitivity, the detection limit corresponding to 70 
copies of objective gene segments. There were 
no signs indicating the amplification of common 
pathogens such as Peste des petits ruminant’s 
virus, Epidemic encephalitis B virus, pasteurella, 
Escherichia coli, and Salmonella. Considering 
that there is no RVFV in China, and in the light of 
the specificity of RVFV and the strict 
requirements for pathogen operation, the 
feasibility and reliability of the constructed 
method were not verified by detecting RVFV 
pathogens. As a reference, however, in an 
artificial synthesis of the genes, the objected 
gene segments were amplified inside the gene 
segments using the proposed method [16]. On 
this basis, a theoretical basis for, and a 
guarantee of the reliability of, the method were 
provided in terms of extraction of RVFV gene 
groups in pathogen detection and the correct 
acquisition of cDNA of the objective gene 




The developed RT-LAMP assay provides a rapid 
method for RVFV detection with high sensitivity 
and good specificity. It can, therefore, serve as a 
back-up technique for the prevention of RVFV 
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